Wall Street Analysts Think Merck (MRK) Is a Good Investment: Is It?

The article compares brokerage analyst recommendations (ABR) with Zacks Rank as investment decision tools. While Merck has a favorable average brokerage recommendation of 1.67 (Buy-equivalent), the article cautions that brokerage firms often exhibit positive bias due to vested interests. Zacks Rank, based on earnings estimate revisions rather than analyst opinions, is presented as a more reliable predictor of near-term stock price movements. Merck received a Zacks Rank #3 (Hold) due to unchanged earnings estimates, suggesting caution despite the bullish brokerage consensus.